Reply: Noninferiority of 6 Versus 12 Months of Dual Antiplatelet Therapy: SECURITY Did Not Establish Noninferiority

Free article

Comment

Antonio Colombo et al. J Am Coll Cardiol. 2015.

Free article

. 2015 Jun 2;65(21):2360-1.

doi: 10.1016/j.jacc.2015.03.548.

No abstract available

Comment on

Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial.
Colombo A, Chieffo A, Frasheri A, Garbo R, Masotti-Centol M, Salvatella N, Oteo Dominguez JF, Steffanon L, Tarantini G, Presbitero P, Menozzi A, Pucci E, Mauri J, Cesana BM, Giustino G, Sardella G. Colombo A, et al. J Am Coll Cardiol. 2014 Nov 18-25;64(20):2086-97. doi: 10.1016/j.jacc.2014.09.008. Epub 2014 Sep 15. J Am Coll Cardiol. 2014. PMID: 25236346 Clinical Trial.
Noninferiority of 6 versus 12 months of dual antiplatelet therapy.
Kaneda H. Kaneda H. J Am Coll Cardiol. 2015 Jun 2;65(21):2359. doi: 10.1016/j.jacc.2015.02.069. J Am Coll Cardiol. 2015. PMID: 26022832 No abstract available.
SECURITY Did Not Establish Noninferiority.
Perneger T. Perneger T. J Am Coll Cardiol. 2015 Jun 2;65(21):2359-60. doi: 10.1016/j.jacc.2015.03.547. J Am Coll Cardiol. 2015. PMID: 26022833 No abstract available.